Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04141839 · ClinicalTrials.gov registry record · NA
Evaluation of the Safer Bars Prevention Program for Sexual Assault
A NA study of Sexual Assault Precursor Behavior, sponsored by Mary Koss.
- Completed
- Registry status
- NA
- Development phase
- 681
- Enrollment target
- 1
- Study location
NCT04141839: Completed NA study of Sexual Assault Precursor Behavior, sponsored by Mary Koss.
NCT04141839 is a NA study of Sexual Assault Precursor Behavior that has completed, run by Mary Koss. The registered enrollment target is 681 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04141839, a NA study of Sexual Assault Precursor Behavior, has completed, sponsored by Mary Koss.
- COMPLETED
- Registry status
- NA
- Development phase
- 681 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal is to evaluate at three sites the implementation of the Safer Bars sexual assault prevention program.
Primary Outcome
Self-reported survey items measuring actual behavior (action taken) in response to observation of sexual aggression in the bar environment will be analyzed to identify significant differences post-intervention.
Conditions Studied
Interventions
- BEHAVIORAL Safer Bars
Study Locations (1)
Arizona
- University of Arizona - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 681 participants |
| Start Date | 2020-10-16 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the finished NCT04141839 record still lists
NCT04141839 is an interventional study that assigns participants to a tested intervention. The registered 681 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (51% lower).
The record links to 1 condition, with Sexual Assault Precursor Behavior appearing as the primary indexed condition, and to 1 intervention - of which Safer Bars is the first listed.
NCT04141839 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT04141839 about?
NCT04141839 is a clinical study titled "Evaluation of the Safer Bars Prevention Program for Sexual Assault". The goal is to evaluate at three sites the implementation of the Safer Bars sexual assault prevention program.
What is the current status of trial NCT04141839?
This trial is currently completed. It is a NA study. The enrollment target is 681 participants. The study started on 2020-10-16. Estimated completion is 2024-12-31.
What conditions does trial NCT04141839 study?
This clinical trial studies the following conditions: Sexual Assault Precursor Behavior.
What interventions are being tested in trial NCT04141839?
The interventions under investigation include: Safer Bars (BEHAVIORAL).
Who is sponsoring clinical trial NCT04141839?
This trial is sponsored by Mary Koss, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04141839 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04141839's enrollment target sits among peer trials
681 151st of 2000 higher than 1,850 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05382559 · 681 participants · Phase 1
A Study of ASP3082 in Adults With Advanced Solid Tumors
- NCT03501706 · 680 participants · NA
An Assessment of Cognitive Improvement Training Among Mid-life Individuals
- NCT05626452 · 680 participants · NA
PrEP Optimization Among Women to Enhance Retention and Uptake
- NCT05753748 · 680 participants · NA
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI